Search Results

You are looking at 11 - 20 of 22 items for :

  • "congenital heart disease" x
  • Medical and Health Sciences x
  • User-accessible content x
Clear All
Orvosi Hetilap
Authors: Dávid Zakariás, Gábor Marics, Kata Kovács, Ágnes Jermendy, Barbara Vatai, György Schuster, Péter Tóth-Heyn, Attila Szabó J. and Csaba Lódi

Norozi K, Beck C, Osthaus WA, et al. Electrical velocimetry for measuring cardiac output in children with congenital heart disease. Br J Anaesth. 2008; 100: 88–94. 20 Liu Y

Open access

[accessed: June 21, 2020]. 13 Hemphill NM, Kuan MT, Harris KC. Reduced physical activity during COVID-19 pandemic in children with congenital heart disease. Can J Cardiol

Open access
Orvosi Hetilap
Authors: János Imre Barabás, Tivadar Hüttl, István Hartyánszky, Levente Fazekas, Zoltán Oláh, Endre Zima, Erzsébet Paulovich, Andrea Kőszegi and Zoltán Szabolcs

surgery. Ann. Thorac. Surg., 2013, 96 (1), 326. Opić, P., van Kranenburg, M., Yap, S. C., et al.: Complications of pacemaker therapy in adults with congenital heart disease: a multicenter study. Int. J. Cardiol

Open access
Acta Veterinaria Hungarica
Authors: Károly Vörös, Viktória Szilvási, Ferenc Manczur, Ákos Máthé, Jenő Reiczigel, Ingo Nolte and Stephan Hungerbühler

Dachshunds . Vet. Rec . 152 , 293 – 3 . Patterson , D. F. ( 1968 ): Epidemiologic and genetic studies of congenital heart disease in the dog . Circ. Res . 23 , 171 – 3

Open access
Interventional Medicine and Applied Science
Authors: Tejaswi Jadhav, Hashir Kareem, Krishnananda Nayak, Umesh Pai, Tom Devasia and Ramachandran Padmakumar

congenital heart disease were excluded. Various echocardiographic parameters were assessed for each patient 1 day prior to surgery, 3–5 days after surgery, and at 1-month follow-up. Medications including angiotensin-converting enzyme inhibitor and beta

Open access

outcomes for left ventricular noncompaction in children with congenital heart disease. Cardiol. Young, 2007, 17 , 56–63. Wilkinson J. Angiographic diagnosis, prevalence and outcomes

Open access

hypertension and other pulmonary artery obstructions  1.4.4. Congenital heart disease  1.4.5. Schistosomiasis 4.1. Chronic

Open access

/g in the liver). As a consequence of methylone use, striated heart muscle damage was observed. Steatosis of the heart muscle, congenital heart disease, and bronchial asthma were listed as potential facilitators of the drug-induced death, with relatively

Open access

than in control subjects. Interestingly, there was a difference in FGF-2 concentrations according to etiologies of PH, with the highest levels seen in patients with primary PAH compared to patients with congenital heart disease or connective tissue

Open access

mtsa: Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J. Pediatr., 1981, 99 , 223–227. Zonanan J. Coloboma, congenital heart

Open access